HilleVax, Inc.
HLVXDelisted Sep 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001888012
HilleVax, Inc. was delisted on Sep 17, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 74 institutions reported holding it in 13F filings for Q2 2025, worth $82.5M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in HilleVax, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 79
- −14 vs. Q2 2024
- Shares held
- 41.7M
- −1.67M (−3.8%) vs. Q2 2024
- Total value
- $73.5M
- −$554.1M (−88.3%) vs. Q2 2024
- New holders
- 23
- 26 more added
- Sold out
- 37
- 18 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HLVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 74 | $82.5M |
| Q1 2025 | 81 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 94 | $657.8M |
| Q1 2024 | 81 | $730.0M |
| Q4 2023 | 69 | $678.3M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.2M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 51 | $399.9M |
| Q2 2022 | 57 | $253.7M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding HilleVax, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −23,401−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −23,077−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −18,109−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −17,724−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −17,118−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −15,688−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −13,299−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −13,066−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −10,874−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,409−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −832−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |